The effect of challenge method on methacholine-induced changes in sensitivity and air trapping  by Segura, Carmen et al.
Respiratory Medicine (2011) 105, 37e43ava i lab le at www.sc iencedi rec t .com
journa l homepage: www.e lsev ier .com/ locate / rmedThe effect of challenge method on methacholine-
induced changes in sensitivity and air trappingCarmen Segura b, Luis Prieto a,*, Victoria Lopez c, Desiree Barato c,
Carmen Perez c, Julio Marı´n aaUniversidad de Valencia, Valencia, Spain
b Servicio de Alergologia, Hospital Virgen Macarena, Sevilla, Spain
c Seccion de Alergologı´a, Hospital Universitario Dr Peset, Valencia, Spain
Received 20 April 2010; accepted 13 July 2010





Airway responsiveness* Corresponding author at: Departam
Tel.: þ34 961622477; fax: þ34 961622
E-mail address: prieto_jes@gva.es
0954-6111/$ - see front matter ª 201
doi:10.1016/j.rmed.2010.07.008Summary
Background: The methacholine challenge test performed with the tidal breathing method
induces a greater fall in FEV1 than the dosimeter method; however, the effect of the challenge
method on methacholine-induced fall in FVC has not been investigated.
Objective: To determine the influence of the challenge method on methacholine-induced
changes in FEV1 and FVC.
Methods: Airway responsiveness to methacholine was determined by dosimeter method and
tidal breathing method in 37 subjects with suspected asthma. The dosimeter was modified
to deliver an identical volume to that obtained with the tidal breathing method and the same
nebulizer model was used for the two challenges. The response was expressed by the provoc-
ative concentration of methacholine causing a 20% fall in FEV1 (PC20) and by the percent fall in
FVC at the PC20 value relative to FVC after saline inhalation.
Results: The PC20 values obtained with the tidal breathing method and the dosimeter method
were similar, with geometric mean values of 3.15 (95%CI, 1.85e5.34 mg/mL) and 2.51
(1.37e4.61 mg/mL, PZ 0.092), respectively. The percent fall in FVC at the PC20 value obtained
with the dosimeter was significantly greater than that obtained with the tidal breathingmethod,
withmeanvalues of 11.8 (95%CI, 10.0e13.5%) and9.4 (95%CI, 8.1e10.8,PZ0.002), respectively.
Conclusions: Differences in methacholine PC20 values obtained with the two challenge methods
recommended in guidelinesmay be overcome by introducing some technical modifications in the
dosimeter method. However, the technical factors that affect methacholine sensitivity and air
trapping are at least partially different.
ª 2010 Elsevier Ltd. All rights reserved.ento de Medicina, Facultad de Medicina y Odontologı´a, Avda Blasco Iba´n˜ez 15, 46010 Valencia, Spain.
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38 C. Segura et al.Introduction challenge method may have some effect on the FVC fallThe identification of the response to inhaled methacholine
is a frequently used method to detect the presence of
increased responsiveness in asthma.1 During routine bron-
choprovocation procedures, the response is generally
expressed as the provocation concentration of methacho-
line that caused a decrease in forced expiratory volume in
1 s (FEV1) of 20% (PC20). However, it has long been appre-
ciated that during bronchoconstriction induced by meth-
acholine, residual volume increases2 (air trapping) and
forced vital capacity (FVC) decreases3 significantly. FVC is
defined as the maximum amount of air that can be mobi-
lized with a single forced expiratory manoeuvre, i.e. the
difference between total lung capacity (TLC) and residual
volume (RV).4 Hence, the size of FVC depends on the
determinants both of TLC and RV. Assuming that during
induced bronchoconstriction, TLC remains constant,5 this
air trapping could be measured by the dose-dependent
decline in FVC. In addition, because lung volume is a major
determinant of the maximal bronchoconstrictor response to
inhaled methacholine,6 it has been suggested7,8 that
changes in FVC may reveal information about the under-
lying asthma pathogenesis that is not apparent from the
changes in FEV1.
At present, two methods of inhalation challenge have
been used. The first consists of the continuous generation
of aerosol and inhalation by quiet tidal breathing for
2 min1; the second consists of intermittent aerosolization
with the use of a breath-activated dosimeter for five
inhalations.9 Both methods of methacholine challenge
testing are recommended by American Thoracic Society10
and European Respiratory Society11 guidelines. Although
the tidal breathing method exposes individuals to a higher
volume of aerosol delivered to the mouth than the dosim-
eter method,12 some studies have reported that the two
methods give comparable results for methacholine sensi-
tivity (PC20 value).
13,14 Recently, two independent groups
have demonstrated that the tidal breathing method
produces methacholine PC20 values significantly lower than
the dosimeter method.15,16 The dosimeter method gener-
ates less positive responses (higher PC20) for two reasons.
The first reason is because the dosimeter delivers a lower
dose. The second reason is because the dosimeter method
involves 5 deep inhalations of methacholine to TLC, and
this is known to be a marked bronchodilator and broncho-
protector manoeuvre.17e19 It has been recently demon-
strated that, even using nebulization methods that deliver
an identical volume of aerosol to the mouth, the meth-
acholine challenge performed with the tidal breathing
method produces PC20 values significantly lower than the
dosimeter method.20 Therefore, the significantly reduced
response to the dosimeter method is thought to be due to
the bronchoprotective effect of the five deep inhalations,
which are an integral part of the dosimeter method. In
these previous studies,15,20 however, a different nebulizer
model was used for each challenge method and, therefore,
we cannot reject that differences in the response between
the two challenge methods may be due to differences in
physical characteristics of the aerosol generated by each
method. Furthermore, it remains unclear whether theinduced by methacholine. The aim of the present study was
to determine the influence of the challenge method on
methacholine-induced changes in FEV1 and FVC, using the
same nebulizer model for the two challenge methods and
high concentrations of methacholine.
Patients and methods
Thirty-seven subjects undergoing methacholine challenge
for clinical evaluation of suspected asthma were recruited
from our outpatient Allergy Clinic. They were selected on
the basis of a PC20 value 100 mg/mL with the first
challenge. At the time of the study, FEV1 was at least 70%
of predicted. No subject had a history of respiratory tract
infections during the 4 weeks before the study. The
study protocol was approved by the local ethics
committee, and written informed consent was obtained
from all participants.
Study design
This was an open, randomized, crossover study. Patients
attended the laboratory on 3 days at the same time each
day. On the first day, all the patients were evaluated for
suitability, anthropometric and clinical characteristics
were recorded, and spirometry was performed. On each of
the next two visits (at least 1 day but not >5 days apart),
spirometry and methacholine challenge using either the
tidal breathing or the dosimeter method were performed.
The two methacholine challenges were performed in
random order. Short-acting inhaled b2-agonists and ipra-
tropium bromide were withheld for at least 6 h before each
challenge, inhaled corticosteroids for at least 4 weeks,
long-acting inhaled b2-agonists for at least 24 h, and oral
antihistamines for at least 72 h. No other asthma medica-
tions were used.
Pulmonary function
Lung function was measured using a calibrated pneumo-
tachograph (Jaeger MasterScope, Erich Jaeger GmbH,
Wu¨rzburg, Germany) according to standardized guidelines.4
Baseline FEV1 and FVC were measured until 3 reproducible
recordings differing less than 5% were obtained. The time
course of the preceding inspiration was standardized, i.e.
a rapid maximal inspiration without end inspiratory pause.
The FVC manoeuvre was continued until a plateau in the
volume-time curve display was obvious or exhalation
exceeded 6 s. Manoeuvres were accepted as technically
satisfactory if the back-extrapolated volume was less than
100 mL or 5% FVC and if the expiratory time was at least 6 s.
The highest values were used for analysis. Reference values
were those of the European Community for Coal and Steel.21
Methacholine challenge procedures
Airway responsiveness to methacholine was assessed using
a standardized tidal breathing method.1 Following baseline
spirometry, FEV1 and FVC were measured after inhalation
Effect of the challenge method on FEV1 and FVC 39of isotonic sodium chloride for 2 min, followed by doubling
concentrations of methacholine (Sigma Chemical, St Louis,
MO) solutions in isotonic sodium chloride in concentrations
of 0.095e100 mg/mL. Aerosols were delivered by means of
a Mefar nebulizer (Mefar, Brescia, Italy) with 2 mL of test
solution in the container. At these conditions, the
mean  SD output of the nebulizer is 0.13  0.015 mL/min
and, at each concentration, the subject is exposed12,22 to
approximately 90 mL of aerosol (0.13 mL/min for
2 min  duty cycle approximately 0.35). The nebulizer
delivers particles with an aerodynamic mass median diam-
eter of 3.5 mm (geometric SD, 2.8 mm). Both FEV1 and FVC
were measured 60e90 s after inhalation of each concen-
tration. The FVC maneuver was continued until a plateau in
the volume-time curve was achieved by visual inspection,
and the minimum duration of the FVC maneuver was 6 s.
Patients inhaled the aerosolized solutions trough a mouth-
piece with their nose clipped. The test was stopped when
either FEV1 fell by 20% or more from baseline measured
after saline inhalation or 100 mg/mL methacholine
concentration was reached.
The dosimeter techniquewasmodified10 from themethod
described by Chai et al.9 Aerosols were generated using the
same nebulizer model as the tidal breathing method,
attached to a breath-activated dosimeter (model MB3;
Mefar; Brescia, Italy) at a nebulization time of 1.5 s, an
activation pressure of 2.0 bar, and a pause time of 6 s. With
these conditions, thenebulizer showedanoutput of 18mLper
actuation and, therefore, the subject was exposed12,22 to
approximately 90 mL of aerosol (18 mL/actuation 5 breaths)
at each concentration. The five-breath dosimeter meth-
acholine challenge was performed using identical meth-
acholine solutions, starting concentrations, and FEV1 and
FVC timing as the tidal breathingmethod.Only the inhalation
method was different. Patients inhaled the aerosolized
solutions in five inhalations from functional residual capacity
to TLC through a mouthpiece with their nose clipped.
Statistical analysis
Methacholine PC20 was calculated using an algebraic
formula.23 The study had >90% power to detect a one-half
concentration difference in PC20.
Occurrence of air trapping during airway narrowing was
determined by the percent fall in FVC at the PC20 value
relative to FVC after saline inhalation, calculated using log-
linear interpolation.24 With this approach, the percent fall
in FVC became the dependent variable (response) and the
degree of airway narrowing (20% fall in FEV1) became the
independent variable. Alternatively, the degree of air
trapping during airway narrowing was also inferred from the
linear regression of the FVC values recorded at each step of
the challenge against the corresponding FEV1 values.
7,25 In
this analysis, the slope of FVC vs FEV1 values quantifies the
amount of air trapping associated with airway narrowing,
with a value of zero indicating airway narrowing with no air
trapping. Therefore, a low slope of FVC indicates the
occurrence of airway narrowing with a small or no incre-
ment in residual volume, and vice versa.
Methacholine PC20 values are not normally distributed
because demonstrate a skewed distribution with a long tailinto the high range of values. Consequently, all PC20 values
were log-transformed before analysis and are presented as
geometric means with 95% confidence intervals (CIs). All
other numerical variables are reported as arithmetic means
with 95% CIs. Numerical variables were analyzed using
paired t tests. Differences in PC20 values are expressed in
terms of doubling concentrations of methacholine calcu-
lated as Dlog PC20/log 2. In addition, differences in PC20,
percent fall in FVC at PC20 and slope of FVC vs FEV1 values
between the tidal breathing and dosimeter methods were
shown graphically by plotting the difference against the
mean, as recommended by Bland and Altman26; P values
were two sided, and values <0.05 were considered statis-
tically significant.Results
Baseline characteristics of the patients are presented in
Table 1. Mean baseline FEV1 and FVC values before each
methacholine challenge were not significantly different
(P Z 0.06 and PZ 0.14, respectively) (Table 1). The order
of the challenge methods had no influence on the PC20
values (P Z 0.32).
Changes in FEV1 induced by each challenge method
The geometric mean (95% CI) PC20 values were 3.15 mg/mL
(1.85e5.34 mg/mL) with the tidal breathing method,
compared with 2.51 mg/mL (1.37e4.61 mg/mL, PZ 0.092)
with the dosimeter method (Fig. 1). PC20 values obtained
with the tidal breathing and the dosimeter method are
shown in Fig. 2 as differences between values obtained with
each method plotted against the mean according to Bland
and Altman.26 The mean difference in the PC20 values
detected with each method was 0.33 doubling concentra-
tions (95% CI, 0.06 to 0.71 doubling concentrations). In
addition, there was no indication of greater variability in
the difference between the 2 measurements as the PC20
increases (Fig. 2).
Changes in FVC induced by each challenge method
The percent fall in FVC at the PC20 value obtained with the
dosimeter was significantly greater than that obtained with
the tidal breathing method (Fig. 3), with mean values of
11.8% (95% CI, 10.0e13.5%) and 9.4% (95% CI, 8.1e10.8%,
PZ 0.002), respectively. Values for the percent fall in FVC
at the PC20 obtained with the tidal-breathing and the
dosimeter method are shown in Fig. 4 as differences
between values obtained with each method plotted against
the mean according to Bland and Altman.26 The mean
difference in the percent fall in FVC values obtained with
each method was 2.3% (95% CI, 0.9e3.8%).
When air trapping during methacholine-induced bron-
choconstriction was expressed as the slope of FVC vs FEV1
values, the mean (95% CI) values were 0.86 (0.75e0.97) on
the dosimeter study day and 0.69 (0.59e0.79, P Z 0.001)
on the tidal-breathing study day (Fig. 5). Differences
between values obtained with each method plotted against
the mean are shown in Fig. 6. The mean difference in the
Table 1 Subject characteristics at baseline.a
Characteristics Data
Age, yr 39 (35e42)
Male/female gender 17/20
Positive skin prick test results 33
FEV1, % predicted 100 (97e104)
FVC, % predicted 112 (108e116)
FEV1/FVC, % 75 (74e77)
BMI 26.9 (25.7e28.2)
Prechallenge FEV1, L
Tidal breathing method 3.30 (2.99e3.61)
Dosimeter method 3.24 (2.92e3.55)
Prechallenge FVC, L
Tidal breathing method 4.38 (4.00e4.77)
Dosimeter method 4.33 (3.94e4.73)
a Data are presented as No or mean (95% CI); FEV1 Z forced































Figure 2 Difference between the tidal breathing and
dosimeter measurements of PC20 (i.e. tidal breathing-dosim-
eter) plotted against the mean of the two values in the 37
subjects studied. Continuous line indicates the mean differ-
ence; dashed lines indicate 2SDs for the differences.
40 C. Segura et al.slope of FVC vs FEV1 values obtained with each method was
0.17 (95% CI, 0.07e0.26).
Correlations
There was no significant correlation between the percent
fall in FVC and PC20 values (rZ 0.31, PZ 0.06 for the tidal-
breathing method and r Z 0.01, P Z 0.97 for the
dosimeter). The slope of FVC vs FEV1 and PC20 values were
also not significantly related (r Z 0.16, P Z 0.36 for the
tidal-breathing method and r Z 0.06, P Z 0.77 for the
dosimeter).
Discussion
In this study, we have found that differences in the effect


















Figure 1 Comparison of tidal breathing and dosimeter PC20
values in the 37 subjects with suspected asthma. Horizontal
lines indicate geometric means.performed with the tidal breathing and the dosimeter
methods may be overcome by introducing some technical
modifications in the dosimeter method and using the same
nebulizer for both challenge tests. However, even incor-
porating these technical changes, the dosimeter method
induces greater changes in FVC than the tidal breathing
method. The results of this study provide new information
about the effects of the challenge method on the air
trapping induced by methacholine and are consistent with
the conclusion that the technical factors that affect
methacholine sensitivity (FEV1 fall) and air trapping (FVC
fall) are at least partially different.
Previous studies have demonstrated that the tidal
breathing method produces methacholine PC20 values
significantly lower than the dosimeter method.12,15,16
Although the cause of these differences between the two
challenge methods is not definitively established, it has






































Figure 3 Comparison of the fall in FVC at the PC20 value































Mean FVC fall at the PC20 value (%)
Figure 4 Difference between the tidal-breathing and the
dosimeter measurements of the FVC fall at the PC20 value
(dosimeter e tidal breathing) plotted against the mean of the
two values. Continuous line Z mean difference; dashed
lines Z 2SDs for the differences. There was no indication of






















Mean slope FVC 
Figure 6 Difference between the tidal-breathing and the
dosimeter measurements of the slope of FVC vs FEV1 values
(dosimeter e tidal breathing) plotted against the mean of the
two values. Continuous line Z mean difference; dashed
lines Z 2SDs for the differences. There was no indication of
a greater difference between the two methods when the slope
of FVC value increased.
Effect of the challenge method on FEV1 and FVC 41volume of aerosol delivered to the mouth. In line with this
suggestion, it has been reported that the volume of aerosol
delivered to the mouth using five inhalations with the
dosimeter (approximately 45 mL) is substantially lower than
the volume administered with the tidal breathing method12
(approximately 90 mL). However, we have recently reported
that, even when the dose of bronchoconstrictor adminis-
tered with the two methods was identical, the dosimeter
method is associated with higher PC20 values than the tidal
breathing method.20 Consequently, it appears that the
volume of aerosolized bronchoconstrictor is not the critical
factor that determines the difference in PC20 values
between the dosimeter and tidal breathing methods. In this
previous investigation,20 however, each challenge method
was performed with different nebulizer models and the
















Figure 5 Individual values for the slope of FVC recorded at
each step of the challenge against the corresponding FEV1
values obtained with the tidal breathing and the dosimeter
method. Horizontal lines indicate means.tidal breathing method was smaller than the mean particle
size generated by the nebulizer used for the dosimeter
method. By contrast, in the present study the same nebu-
lizer model was used for both challenge methods and our
results clearly demonstrate that methacholine PC20 value
obtained with the two methods is similar. Therefore, it
appears that differences in the PC20 values reported in
previous studies12,15,16 might be due to differences in
particle size of the aerosol generated between the nebu-
lizers used for each method. Another explanation might be
differences in evaporative losses during routine operation
between different jet nebulizers, with the subsequent
differences in the concentration in remaining solute in the
nebulizer.27
To our knowledge, this is the first study designed to
identify the effect of challenge method on methacholine-
induced changes in air trapping, as reflected by decline in
FVC. Our results demonstrate that, although differences
are small, the methacholine-induced reduction in FVC is
significantly greater with the dosimeter method. These
results seem to indicate that, even when the two challenge
methods are performed using the same nebulizer model
and a similar volume of nebulized solution is delivered to
the mouth, the dosimeter method is associated with
a greater degree of air trapping than the tidal breathing
method. The cause(s) for these different effects of chal-
lenge method on methacholine-induced changes in FEV1
and FVC are not evident, but we can purpose some
hypothesis. First, it is known that histamine-induced
declines in FVC are related to some extent to the baseline
airway caliber.28 Thus, the greater effect on FVC of the
methacholine challenge performed with the dosimeter
method compared with the tidal-breathing method might
be consequence of differences in baseline FEV1. In our
patients, the FEV1 values before the dosimeter method
tended to be significantly lower (P Z 0.06) than those
obtained before the tidal breathing method. However, we
believe that our results are not affected significantly by this
factor because the PC20 values, which are obtained from
changes in FEV1 and, therefore, are more directly depen-
dent from baseline FEV1 values, were similar for the two
42 C. Segura et al.challenge methods. Second, during methacholine challenge
testing using the dosimeter method, each concentration of
methacholine is inhaled by five deep inspirations to TLC.10
These manoeuvers may have the potential to cause
a bronchodilator and a bronchoprotector effect.17e19,29 It
has been recently demonstrated that five deep inspirations
from functional residual capacity to TLC before meth-
acholine challenge protect against air trapping identified by
changes in FVC in non-asthmatic but not in asthmatic
subjects.30,31 These results may be relevant to the present
discussion. We selected subjects with suspected asthma
and consequently some of our patients were non-asth-
matic. Therefore, differences in air trapping induced by
each challenge method might be due to the bronchodilator
and bronchoprotector effect of the five deep inhalations
inherent to the dosimeter method. However, the effect of
deep inhalations performed with the dosimeter method
would have had the opposite effect (lower FVC fall with the
dosimeter method) to that which we observed. Third, it has
been suggested that the dosimeter method results in
greater deposition and retention of the aerosol in the lower
airways,10 with the subsequent development of peripheral
airway closure32 and air trapping. Although we have shown
that the volume of aerosol delivered to the mouth by the
two methods is identical,19 improved deposition and
retention should increase the response to methacholine.
We cannot reject, therefore, that differences in the
methacholine-induced changes in air trapping between the
two challenge methods may be due, at least in part, to
a greater lung penetration and deposition of the aerosol
with the dosimeter method than with the tidal breathing
method. Finally, in addition to air trapping, other potential
mechanisms that may contribute to the reduction in FVC
during induced bronchoconstriction include early termina-
tion of expiratory effort and reduced breath holding.2 We
believe, however, that these factors cannot be considered
to be responsible for the decline in FVC in the present
patients, because of the protocol used for lung function
measurement. Whatever the cause for these differential
effects on FVC of the two challenge methods, our findings
clearly show that the ease of bronchoconstriction, as
reflected by the PC20, and the degree of air trapping, as
reflected by the percent fall in FVC, are modified differ-
entially by technical factors.
The present results have clinical implications. Firstly, our
results clearly demonstrate that, when the two challenge
methods are performed using the same nebulizer model and
delivering a similar volume of nebulized solution to the
mouth, methacholine PC20 values obtained with the dosim-
eter method are comparable to those identified with the
tidal breathing method. Therefore, the same cut-off point
for methacholine PC20 can be used with both challenge
methods and the PC20 values obtained with each method can
be comparable. Secondly, it is now generally accepted that
asthma is a disease in which the airways narrow too easily
and too much in response to a wide variety of stimuli that
have little or no effect on the normal lung.33 Airway nar-
rowing that occurs too easily (airway sensitivity) is assessed
by measuring the PC20 value. However, this measure does
not assess excessive bronchoconstriction, and previous
studies33e35 have focused on the importance of character-
izing the entire methacholine dose-response curve not onlyby sensitivity but also by the maximal airway narrowing
response value (plateau). Bronchoprovocation tests that
employ high concentrations of methacholine to measure the
maximal response plateau directly are not practical for
clinical use because of the risks inherent in producing an
excessive fall in FEV1. Therefore, a new test to quantify
excessive bronchoconstriction would be desirable. Because
lung volume is a major determinant of the maximal bron-
choconstrictor response to methacholine,6 it has been sug-
gested that changes in FVC may represent an indirect
method for the detection of plateau24 and may reveal
information about the underlying asthma pathogenesis that
is not apparent from the changes in FEV1.
14 The results of
the present study indicate that the modified dosimeter
method is associated with a greater degree of air trapping as
reflected by decline in FVC than the tidal breathing method.
This data suggests that the methacholine-induced effects on
air trapping identified with the two challenge methods are
not comparable.
In conclusion, we have found that differences in meth-
acholine PC20 values obtained with the two challenge
methods recommended in guidelines may be overcome by
introducing some technical modifications in the dosimeter
method. With these technical changes, however, the meth-
acholine challenge performed with the dosimeter method is
associated with a greater degree of air trapping than the
tidal breathing method. This is important for interpretation
and comparison of the results obtained using the two
methods of testing.Conflict of interest
The authors have no conflict of interest with regard to the
work in this publication.
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